［8］NAGY B，ZSOLYOM A，NAGYJANOSI L，et of a risk based secondary screening program of type 2 diabetes［J］.Diabetes/Metabolism Research & Reviews，2016，32（7）：：10.1002/

［9］SCHAUFLER T M，WOLFF M.Cost effectiveness of preventive screening programmes for type 2 diabetes mellitus in Germany［J］.Applied Health Economics & Health Policy，2010，8（3）：：10.2165/-000000000-00000.

［10］CHAUDHARI P，VALLARINO C，LAW E H，et of patients with type 2 diabetes mellitus receiving treatment during the pre-diabetes period：is early treatment associated with improved outcomes?［J］.Diabetes Research and Clinical Practice，2016，122：：10.1016/

［11］SCHWAB P，SAUNDANKAR V，BOUCHARD J，et al.Early treatment revisions by addition or switch for type 2 diabetes：impact on glycemic control，diabetic complications，and healthcare costs［J］.BMJ Open Diabetes Research and Care，2016，4（1）：1-7.DOI：10.1136/bmjdrc-2015-000099.

［12］GOODALL G，SARPONG E M，HAYES C，et al.The consequences of delaying insulin initiation in UK type 2 diabetes patients failing oral hyperglycaemic agents：a modelling study［J］.BMC Endocrine Disorders，2009，9（1）：1-9.DOI：10.1186/1472-6823-9-19.

［13］MOHAMED Q，GILLIES M C，WONG T of diabetic retinopathy：a systematic review［J］.Journal of American Medical Association，2007，298（8）：902-916.

［14］JAVITT J C，AIELLO L P，CHIANG Y，et eye care in people with diabetes is cost saving to the federal government：implications for health-care reform ［J］.Diabetes Care，1994，17（8）：909-917.

［15］JAVITT J C，AIELLO L of detecting and treating diabetic retinopathy［J］.Annals of Internal Medicine，1996，124（1）：164-169.

［16］VIJAN S，HOFER T P，HAYWARD R analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus［J］.Journal of American Medical Association，2000，283（7）：889-896.

［17］LUND S H，ASPELUND T，KIRBY P，et risk ssessment or diabetic etinopathynd optimization of screening intervals：a scientific approach to reducing healthcare costs［J］.British Journal of Ophthalmology，2016，100（5）：：10.1136/bjophthalmol-2015-.

［18］BRECHNER R J，COWIE C C，HOWIE L J，et examination among adults with diagnosed diabetes mellitus［J］.The Journal of the American Medical Association，1993，270（14）：1714-1718.

［19］MABERLEY D，WALKER H，KOUSHIK A，et for diabetic retinopathy in James Bay，Ontario：a cost-effectiveness analysis［J］.Canadian Medical Association Journal，2003，168（2）：160-164.

［20］CORONADO A C，ZARIC G S，MARTIN J，et retinopathy screening with pharmacy-based teleophthalmology in a semi urban setting a cost-effectiveness analysis［J］.CMAJ Op en，2 0 1 6，4（1）：e9 5-1 0 2.DOI：10.9778/cmajo..

［21］NGUYEN H V，TAN G S，TAPP R J，et of a national telemedicine diabetic retinopathy screening program in Singapore［J］.Ophthalmology，2016，123（12）：：10.1016/

［22］SHARMA S，HOLLANDS H，BROWN G C，et al.The costeffectiveness of early vitrectomy for the treatment of vitreous hemorrhage in diabetic retinopathy［J］.Current Opinion in Ophthalmology，2001，12（3）：230-234.

［23］HABIB S H，BISWAS K B，AKTER S，et analysis of medical intervention in patients with early detection of diabetic foot in a tertiary care hospital in Bangladesh［J］.Journal of Diabetes & Its Complications，2010，24（4）：：10.1016/

［24］TENNVALL G R，APELQVIST of diabetes-related foot ulcers and amputations：a cost-utility analysis based on Markov model simulations［J］.Diabetologia，2001，44（11）：2077-2087.

［25］HABIB S H，AKTER S，SAHA S，et analysis of medical intervention in patients with early detected of Diabetic Nephropathy in a tertiary care hospital in Bangladesh［J］.Diabetes & Metabolic Syndrome，2010，4（3）：：10.1016/

［26］HOERGER T J，HICKS K A，SORENSEN S W，et of screening for pre-diabetes among overweight and obese U.S. adults［J］.Diabetes Care，2007，30（11）：2874-2879.

［27］GOZZOLI V，PALMER A J，BRANDT A，et and clinical impact of alternative disease management strategies for secondary prevention in type 2 diabetes in the Swiss setting［J］.Swiss Medical Weekly，2001，131（21/22）：303-310.

文章来源：《经济视野》 网址: http://www.jjsyzz.cn/qikandaodu/2020/0809/459.html